SEC filing · 8-K

Telomir Pharmaceuticals, Inc.: Material agreement

Telomir Pharmaceuticals raised approximately $5.6 million through a common stock private placement to fund clinical development.

Filed October 6, 2026

Positive for the company

What happened

On October 5, 2026, the company agreed to issue and sell 4,843,300 shares of common stock at $1.16 per share in a private placement.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Filing document on SEC.gov Press release (EX-99.1) All documents of this filing

Back to Telomir Pharmaceuticals, Inc.

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.